PATENT CLAIM ANALYSIS

Application Number: 15746001
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "252120"]

Abstract:
Provided in the present invention are a compound PAC-1 in amorphous form, an oral pharmaceutical composition comprising the compound PAC-1 in amorphous form, and a use of the compound PAC-1 in amorphous form in the preparation of the oral pharmaceutical composition. The PAC-1 in amorphous form displays an obviously lower neurotoxicity than PAC-1 in crystal form, and is more suitable for being used to develop drugs for treating diseases such as tumours, especially metastatic tumours and the like.

Claim (Index 1):
A compound PAC-1 represented by the following formula (I), which is in an amorphous form:

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.82609
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14382546', '15243860', '14383460', '13379497', '14263886']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7391543564867503
- 35 USC 102 Novelty (BERT): 0.5121581872190591
- Combined Prediction Score: 0.7164547395599813
- Mean Citation Score: 220.49763
- Max Citation Score: 227.74901
- Similarity Product: 145.9352395313823

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test